Credit Suisse Assumes Target (TGT) at Neutral
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Credit Suisse assumes coverage on Target (NYSE: TGT) with a Neutral rating and a price target of $65.00 (from $72.00).
Analyst Edward Kelly commented, "TGT's recovery has stalled, and its outlook once again is uncertain. Structural headwinds and underinvestment in key segments of the business now seem to be weighing on the company. Margins look poised to head lower over time and consensus estimates carry some risk. Desperately poor sentiment and a low valuation represent the only real points of support at the moment."
Shares of Target closed at $69.21 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- M&T Bank (MTB) PT Raised to $165 at FBR Capital Following 4Q Beat
- Web.com, Inc. (WEB) PT Raised to $25 at BWS Financial Ahead of 4Q Report
- UPDATE: SunTrust Robinson Humphrey Downgrades Health Care REIT (HCN) to Hold
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst PT Change, New Coverage
Related EntitiesCredit Suisse
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!